IP Library Granted Patent US 12,331,312
Granted Patent B2
US 12,331,312 · App. 17/225,708 · Granted Jun 17, 2025

Deterministic culturing of single cells

Inventors: Cagri A. Savran (West Lafayette, IN); Rohil Jain (West Lafayette, IN); Chun-Li Chang (West Lafayette, IN)
Assignee: Purdue Research Foundation
C12N5/0062C12M21/08C12M23/16C12M23/34C12M41/48C12N5/0693C12N5/0697G01N33/5011G01N33/5088C12N2513/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,331,312
App. No.
17/225,708
Granted
Jun 17, 2025
Kind
B2
Abstract

The application relates to methods and systems for culturing individually selected cells in relative isolation from the rest of a population of cells, under physiologically relevant and controllable environmental conditions that can be designed to mimic specific environments, e.g., within a human body.

Claims (26)

1. A method for deterministically culturing one or more single cells into respective multi-cell tissues, the method comprising:

(a) depositing one or more separate droplets of about 0.1 μL to about 100 μL per droplet of a liquid matrix material onto a surface of a culture vessel to form one or more three-dimensional culturing islands attached to the surface of the culture vessel, wherein each culturing island is separated and not in contact with any other culturing island, and wherein each separate culturing island can comprise one or more droplets of a liquid matrix;

(b) allowing the matrix material in each culturing island to solidify, or solidifying each culturing island, wherein the one or more culturing islands become solid or semi-solid;

(c) adding a culture medium to the culture vessel in an amount sufficient to contact, but not completely submerge, each of the culturing islands, wherein the top of each culturing island is not submerged in the culture medium;

(d) selecting one or more parameters of each of the matrix and the culture medium based on one or more micro-environment selection criteria comprising one or more of chemical composition, stiffness, pH, porosity, or presence of one or more specific molecules that facilitate cell attachment, probe cell proliferation, or cause cells to differentiate into organ-specific cells;

(e) selecting one or more single cells from a population of tumor cells, stem cells, or fetal cells using one or more cell selection criteria comprising one or more of an expression level of one or more cell-surface molecules, a morphology of the cell, a shape of the cell, a circularity and aspect ratio of the cell, a stemness of the cell, a proliferation potential of the cell, a type of the cell, a morphology of the nucleus, a presence of nuclear foci, a genetic composition, epigenetic modifications, and/or a secretion of one or more cytokines or chemokines by the cells;

(f) seeding one or more selected single cells onto or into each of the culturing islands, with one single cell seeded per island, and providing a time sufficient to enable the one or more single cells to adhere to a surface of a respective culturing island or adhere to the matrix within the respective culturing island, wherein each of the one or more culturing islands then includes a single cell;

(g) adding additional culture medium in an amount sufficient to submerge the one or more seeded single cells and the one or more culturing islands in the culture medium; and

(h) culturing the one or more single cells on or within the one or more culturing islands for a time and under conditions sufficient to grow one multi-cell tissue from each seeded single cell.

2. The method of claim 1 , wherein the matrix comprises one or more components of an extracellular matrix, selected from the group consisting of collagen, a gelatinous protein mixture that resembles extracellular matrix, elastin, and laminin.

3. The method of claim 2 , wherein the matrix is solidified by cross-linking.

4. The method of claim 1 , wherein the diameter of each of the culturing islands is about 1 mm to about 10 mm.

5. The method of claim 1 , comprising a plurality of culturing islands.

6. The method of claim 5 , wherein a distance between the culturing islands is at least about 1 mm.

7. The method of claim 5 , wherein the culturing islands are separated in individual compartments.

8. The method of claim 1 , wherein the volume of the culturing medium is about 1.0 μL to about 10 μL.

9. The method of claim 1 , wherein the microenvironment mimics a cancer microenvironment.

10. The method of claim 1 , wherein each of the single cells is selected and seeded using a microfluidic device.

11. The method of claim 1 , wherein the culture medium comprises a biological fluid or a liquid extracted from a tissue or gland.

12. The method of claim 11 , wherein the biological fluid is blood, plasma, or lymph fluid.

13. The method of claim 1 , wherein the single cell on each respective culturing island is cultured for about 8 to about 11 days.

14. The method of claim 1 , wherein each single cell is a single tumor cell.

15. The method of claim 14 , wherein the tumor is a colorectal tumor or a breast tumor.

16. The method of claim 14 , wherein the single tumor cell is isolated from a patient.

17. The method of claim 1 , further comprising separating individual cells from the multi-cell tissue(s) and culturing the separated individual cells.

18. The method of claim 1 , further comprising administering a therapeutic agent to the multi-cell tissue(s), thereby testing an effect of the therapeutic agent on the multi-cell tissue(s).

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 6, 2025
From: SAVRAN, CAGRI ABDULLAH; CHANG, CHUN-LI; JAIN, ROHIL
To: PURDUE RESEARCH FOUNDATION
Reel/Frame 071039/0557 →
CONFIRMATORY LICENSE Recorded Jan 16, 2024
From: PURDUE UNIVERSITY
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 066318/0598 →
Continuity (2)
Provisional Application 63036060 · Jun 8, 2020
Related Publication 20210380934A1 · Dec 9, 2021
References Cited (67)
Chen, H., et al., “High-throughput, deterministic single cell trapping and long-term clonal cell culture in microfluidic devices,” Lab on a Chip 15(4): 1072-1083. doi: 10.1039/c4lc01176g (Year: 2015). [cited by examiner]
Aisenbrey, E. A., and Murphy, “Synthetic alternatives to Matrigel,” Nature Reviews Materials. 5(7): 539-551. doi: 10.1038/s41578-020-0199-8. Epub May 27, 2020. (Year: 2020). [cited by examiner]
Guan, Z., et al., “Facile and rapid generation of large-scale microcollagen gel array for long-term single-cell 3D culture and cell proliferation heterogeneity analysis,” Analytical Chemistry 86(5): 2789-2797. doi: 10.1… [cited by examiner]
Mao, A. S., et al., “Deterministic encapsulation of single cells in thin tunable microgels for niche modelling and therapeutic delivery,” Nature Materials 16(2): 236-243. doi: 10.1038/nmat4781. Epub Oct. 31, 2016. (Year… [cited by examiner]
Huang et al., “A microfluidic microwell device for immunomagnetic single-cell trapping,” Microfluidics and Nanofluidics 22, 16. https://doi.org/10.1007/s10404-018-2040-x (Year: 2018). [cited by examiner]
Fang, Y., and Eglen, R. M., “Three-Dimensional Cell Cultures in Drug Discovery and Development” SLAS Discovery 22(5): 456-472. doi: 10.1177/1087057117696795. Published online May 18, 2017 (Year: 2017). [cited by examiner]
Warmflash, A., et al., “A method to recapitulate early embryonic spatial patterning in human embryonic stem cells,” Nat Methods 11(8): 847-854. doi: 10.1038/nmeth.3016. Epub Jun. 29, 2014. (Year: 2014). [cited by examiner]
Wang, H., et al., “Bioinspired One Cell Culture Isolates Highly Tumorigenic and Metastatic Cancer Stem Cells Capable of Multilineage Differentiation,” Adv Sci 7(11): 2000259. doi: 10.1002/advs.202000259. Apr. 28, 2020. … [cited by examiner]
Ratajczak, M. Z., et al., “Very small embryonic/epiblast-like stem cells: a missing link to support the germ line hypothesis of cancer development?,” Am J Pathol 174(6): 1985-1992. doi: 10.2353/ajpath.2009.081143. (Year… [cited by examiner]
Kang, J., et al., “Mini-pillar array for hydrogel-supported 3D culture and high-content histologic analysis of human tumor spheroids,” Lab Chip 16(12): 2265-2276. doi: 10.1039/c6lc00526h. (Year: 2016). [cited by examiner]
Acerbi et al., “Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration,” Integrative Biology, Oct. 5, 2015, 7(10):1120, 16 pages. [cited by applicant]
Albini et al., “A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer research,” Jun. 15, 1987, 47(12):3239-45. [cited by applicant]
Aref et al., “Bowden M. 3D microfluidic ex vivo culture of organotypic tumor spheroids to model immune checkpoint blockade,” Lab on a Chip, Sep. 2018, 18(20):3129-43. [cited by applicant]
Baccelli et al., “Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay,” Nature Biotechnology, Jun. 2013, 31(6):539-44. [cited by applicant]
Beca et al., “Intratumor heterogeneity in breast cancer,” Novel Biomarkers in the Continuum of Breast Cancer, Mar. 2016, 169-89. [cited by applicant]
Bianchi, “Fetal cells in the maternal circulation: feasibility for prenatal diagnosis,” British Journal of Haematology, Jun. 1999, 105(3):574-83. [cited by applicant]
Brauchle et al., “Biomechanical and biomolecular characterization of extracellular matrix structures in human colon carcinomas,” Matrix Biology, Aug. 1, 2018, 68:180, 37 pages. [cited by applicant]
Celià-Terrassa et al., “Distinctive properties of metastasis-initiating cells,” Genes & Development, Apr. 15, 2016, 30(8):892-908. [cited by applicant]
Chen et al., “Microfluidic array for three-dimensional perfusion culture of human mammary epithelial cells.” Biomedical Microdevices, Aug. 2011, 13(4):753-8. [cited by applicant]
Chen et al., “Organotropism: new insights into molecular mechanisms of breast cancer metastasis,” NPJ Precision Oncology, Feb. 16, 2018, 2(1), 12 pages. [cited by applicant]
Chen et al., “Single cell dual adherent-suspension co-culture micro-environment for studying tumor-stromal interactions with functionally selected cancer stem-like cells,” Lab on a Chip, Jun. 2016, 16(15):2935-45. [cited by applicant]
Chen et al.. , “Rare cell isolation and analysis in microfluidics,” Lab on a Chip, Jan. 2014, 14(4):626-45. [cited by applicant]
Cheng et al., “Scaling and automation of a high-throughput single-cell-derived tumor sphere assay chip,” Lab on a Chip, Oct. 2016, 16(19):3708-17. [cited by applicant]
Chittiboyina et al., “Gradient-on-a-Chip with reactive oxygen species reveals thresholds in the nucleus response of cancer cells depending on the matrix environment,” ACS Biomaterials Science & Engineering, Feb. 12, 201… [cited by applicant]
Comet et al., “Maintaining cell identity: PRC2-mediated regulation of transcription and cancer,” Nature Reviews Cancer, Dec. 2016, 16(12):803-10. [cited by applicant]
Corvaisier et al., “Regulation of cellular quiescence by YAP/TAZ and Cyclin El in colon cancer cells: Implication in chemoresistance and cancer relapse,” Oncotarget, Aug. 30, 2016, 7(35):56699, 14 pages. [cited by applicant]
Crowley et al., “Analyzing cell death by nuclear staining with Hoechst 33342,” Cold Spring Harbor Protocols, Sep. 1, 2016, 2016(9):pdb-rot087205, 5 pages. [cited by applicant]
Dagogo-Jack et al., “Tumour heterogeneity and resistance to cancer therapies,” Nature Reviews Clinical Oncology, Feb. 2018, 15(2):81-94. [cited by applicant]
Davis et al., “Tumor dormancy and slow-cycling cancer cells,” Human Cell Transformation, 2019 199-206. [cited by applicant]
Deng et al., “Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from b… [cited by applicant]
Edmondson et al., “Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors,” Assay and Drug Development Technologies, May 1, 2014, 12(4):207, 12 pages. [cited by applicant]
Fang et al., “Three-dimensional cell cultures in drug discovery and development,” Slas Discovery: Advancing Life Sciences R&D, Jun. 2017, 22(5):456-72. [cited by applicant]
Fiddler, “Fetal cell based prenatal diagnosis: perspectives on the present and future,” Journal of Clinical Medicine, Sep. 2014, 3(3):972-85. [cited by applicant]
Fleming et al., “Colorectal carcinoma: Pathologic aspects,” Journal of Gastrointestinal Oncology, Sep. 2012, 3(3):153-73. [cited by applicant]
Gerlinger et al., “Intratumor heterogeneity and branched evolution revealed by multiregion sequencing,” New England Journal of Medicine, Mar. 8, 2012, 366:883-92. [cited by applicant]
Gracz et al., “A high-throughput platform for stem cell niche co-cultures and downstream gene expression analysis,” Nature Cell Biology, Mar. 2015, 17(3):340-9. [cited by applicant]
Hsiao et al., “Microfluidic system for formation of PC-3 prostate cancer co-culture spheroids,” Biomaterials, Jun. 1, 2009, 30(16):3020-7. [cited by applicant]
Ingram et al., “Three-dimensional growth patterns of various human tumor cell lines in simulated microgravity of a NASA bioreactor,” In Vitro Cellular & Developmental Biology-Animal, Jun. 1997, 33(6):459-66. [cited by applicant]
Ishihara et al., “Mechano-signal transduction in mesenchymal stem cells induces prosaposin secretion to drive the proliferation of breast cancer cells,” Cancer Research, Nov. 15, 2017, 77(22):6179-89. [cited by applicant]
Ivanov et al., “Spheroid arrays for high-throughput single-cell analysis of spatial patterns and biomarker expression in 3D,” Scientific Reports, Jan. 30, 2017, 7(1), 13 pages. [cited by applicant]
Janiszewska et al., “The microcosmos of intratumor heterogeneity: The space-time of cancer evolution,” Oncogene, Mar. 2020, 39(10):2031-9. [cited by applicant]
Kelm et al., “Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types,” Biotechnology and Bioengineering, Jul. 20, 2003, 83(2):173-80. [cited by applicant]
Lee et al., “Isolation of spheroid-forming single cells from gastric cancer cell lines: enrichment of cancer stem-like cells,” Biotechniques, Oct. 2018, 65(4):197-203. [cited by applicant]
Lelièvre et al., “Microphysiological systems to study microenvironment-cell nucleus interaction: importance of tissue geometry and heterogeneity,” Microphysiological Systems, Dec. 2018, 2(12):10-21037. [cited by applicant]
Lin et al., “A microfluidic platform for high-throughput single-cell isolation and culture,” Journal of visualized experiments: JoVE, Jun. 2016, (112), 7 pages. [cited by applicant]
Lindström et al., “Single-cell culture in microwells,” Single-Cell Analysis 2012, 853, 41-52. [cited by applicant]
Liu et al., “Controllable organization and high throughput production of recoverable 3D tumors using pneumatic microfluidics,” Lab on a Chip, 2015, 15(4):1195-204. [cited by applicant]
Maheswaran et al., “Ex vivo culture of CTCs: an emerging resource to guide cancer therapy,” Cancer Research, Jun. 15, 2015, 75(12):2411-5. [cited by applicant]
Marusyk et al., “Intra-tumour heterogeneity: a looking glass for cancer?,” Nature Reviews Cancer, May 2012, 12(5):323-34. [cited by applicant]
Meacham et al., “Tumour heterogeneity and cancer cell plasticity,” Nature, Sep. 2013, 501(7467):328-37. [cited by applicant]
Mebta et al., “Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy,” Journal of Controlled Release, Dec. 10, 2012, 164(2):192-204. [cited by applicant]
Paszek et al., “Tensional homeostasis and the malignant phenotype,” Cancer Cell, Sep. 1, 2005, 8(3):241-54. [cited by applicant]
Qureshi-Baig et al., “What do we learn from spheroid culture systems? Insights from tumorspheres derived from primary colon cancer tissue,” PloS one, Jan. 8, 2016, 11(1):e0146052, 24 pages. [cited by applicant]
Scher et al., “Phenotypic heterogeneity of circulating tumor cells informs clinical decisions between AR signaling inhibitors and taxanes in metastatic prostate cancer,” Cancer Research, Oct. 15, 2017, 77(20):5687-98. [cited by applicant]
Schindelin et al., “Fiji: an open-source platform for biological-image analysis,” Nature Methods, Jul. 2012. 9(7):676-82. [cited by applicant]
Schneider et al., “NIH Image to ImageJ: 25 years of image analysis,” Nature Methods, Jul. 2012, 9(7):671-5. [cited by applicant]
Smart et al., “In vitro analysis of breast cancer cell line tumourspheres and primary human breast epithelia mammospheres demonstrates inter- and intrasphere heterogeneity,” PloS one, Jun. 4, 2013, 8(6):e64388, 15 pages. [cited by applicant]
Souza et al., “Three-dimensional tissue culture based on magnetic cell levitation,” Nature Nanotechnology, Apr. 2010, 5(4):291-6. [cited by applicant]
Tibbitt et al., “Hydrogels as extracellular matrix mimics for 3D cell culture,” Biotechnology and Bioengineering, Jul. 1, 2009, 103(4):655-63. [cited by applicant]
Tirier et al., “Pheno-seq-linking visual features and gene expression in 3D cell culture systems,” Scientific Reports, Aug. 26, 2019, 9(1):1-5. [cited by applicant]
Wang et al., “Cell adhesion and mechanical stimulation in the regulation of mesenchymal stem cell differentiation,” Journal of Cellular and Molecular Medicine, Jul. 2013, 17(7):823-32. [cited by applicant]
Wang et al., “Cultured circulating tumor cells and their derived xenografts for personalized oncology,” Asian Journal of Urology, Oct. 1, 2016, 3(4):240-53. [cited by applicant]
Weiswald et al., “Spherical cancer models in tumor biology,” Neoplasia, Jan. 1, 2015, 17(1):1-5. [cited by applicant]
Yu et al., “Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility,” Science, Jul. 11, 2014, 345(6193):216-20. [cited by applicant]
Zhang et al., “Micro RNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR,” Oncotarget, Feb. 2, 2016, 7(5):5702-14. [cited by applicant]
Zhang et al., “Microfluidics 3D gel-island chip for single cell isolation and lineage-dependent drug responses study,” Lab on a Chip, 2016, 16(13):2504-12. [cited by applicant]
Zhau et al., “Establishment of a three-dimensional human prostate organoid coculture under microgravity-simulated conditions: evaluation of androgen-induced growth and PSA expression,” In Vitro Cellular & Developmental … [cited by applicant]